• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TIMM8A 基因突变致耳聋-肌张力障碍-视神经萎缩神经病综合征的功能分析。

Functional analysis of a novel mutation in the TIMM8A gene that causes deafness-dystonia-optic neuronopathy syndrome.

机构信息

Greenwood Genetic Center, Greenwood, SC, USA.

University of South Carolina School of Medicine, Columbia, SC, USA.

出版信息

Mol Genet Genomic Med. 2020 Mar;8(3):e1121. doi: 10.1002/mgg3.1121. Epub 2020 Jan 5.

DOI:10.1002/mgg3.1121
PMID:31903733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7057109/
Abstract

BACKGROUND

The rare, X-linked neurodegenerative disorder, Mohr-Tranebjaerg syndrome (also called deafness-dystonia-optic neuronopathy [DDON] syndrome), is caused by mutations in the TIMM8A gene. DDON syndrome is characterized by dystonia, early-onset deafness, and various other neurological manifestations. The TIMM8A gene product localizes to the intermembrane space in mitochondria where it functions in the import of nuclear-encoded proteins into the mitochondrial inner membrane. Frameshifts or premature stops represent the majority of mutations in TIMM8A that cause DDON syndrome. However, missense mutations have also been reported that result in loss of the TIMM8A gene product.

METHODS

We report a novel TIMM8A variant in a patient with DDON syndrome that alters the initiation codon and employed functional analyses to determine the significance of the variant and its impact on mitochondrial morphology.

RESULTS

The novel base change in the TIMM8A gene (c.1A>T, p.Met1Leu) results in no detectable protein and a reduction in TIMM8A transcript abundance. We observed a commensurate decrease in the steady-state level of the Tim13 protein (the binding partner of Tim8a) but no decrease in TIMM13 transcripts. Patient fibroblasts exhibited elongation and/or increased fusion of mitochondria, consistent with prior reports.

CONCLUSION

This case expands the spectrum of mutations that cause DDON syndrome and demonstrates effects on mitochondrial morphology that are consistent with prior reports.

摘要

背景

罕见的 X 连锁神经退行性疾病,Mohr-Tranebjærg 综合征(也称为耳聋-肌张力障碍-视神经病变[DDON]综合征),是由 TIMM8A 基因突变引起的。DDON 综合征的特征是肌张力障碍、早发性耳聋和其他各种神经表现。TIMM8A 基因产物定位于线粒体的内膜间隙,在那里它在核编码蛋白向线粒体内膜的输入中起作用。移码或过早停止是导致 DDON 综合征的 TIMM8A 基因突变的主要类型。然而,也有报道称错义突变导致 TIMM8A 基因产物缺失。

方法

我们报告了一例 DDON 综合征患者的 TIMM8A 新型变体,该变体改变了起始密码子,并采用功能分析来确定变体的意义及其对线粒体形态的影响。

结果

TIMM8A 基因中的新型碱基变化(c.1A>T,p.Met1Leu)导致无法检测到蛋白质,并降低了 TIMM8A 转录本的丰度。我们观察到 Tim13 蛋白(Tim8a 的结合伴侣)的稳态水平相应下降,但 TIMM13 转录本没有下降。患者成纤维细胞表现出线粒体伸长和/或融合增加,与先前的报道一致。

结论

该病例扩展了导致 DDON 综合征的突变谱,并证明了对线粒体形态的影响与先前的报道一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e03/7057109/076fc35131f9/MGG3-8-e1121-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e03/7057109/f0ed445a7d42/MGG3-8-e1121-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e03/7057109/e3363c6d2260/MGG3-8-e1121-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e03/7057109/076fc35131f9/MGG3-8-e1121-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e03/7057109/f0ed445a7d42/MGG3-8-e1121-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e03/7057109/e3363c6d2260/MGG3-8-e1121-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e03/7057109/076fc35131f9/MGG3-8-e1121-g003.jpg

相似文献

1
Functional analysis of a novel mutation in the TIMM8A gene that causes deafness-dystonia-optic neuronopathy syndrome.TIMM8A 基因突变致耳聋-肌张力障碍-视神经萎缩神经病综合征的功能分析。
Mol Genet Genomic Med. 2020 Mar;8(3):e1121. doi: 10.1002/mgg3.1121. Epub 2020 Jan 5.
2
Phenotype prediction of Mohr-Tranebjaerg syndrome (MTS) by genetic analysis and initial auditory neuropathy.通过基因分析和初始听觉神经病对莫尔-特拉内伯格综合征(MTS)进行表型预测
BMC Med Genet. 2019 Jan 11;20(1):11. doi: 10.1186/s12881-018-0741-3.
3
Human deafness dystonia syndrome is caused by a defect in assembly of the DDP1/TIMM8a-TIMM13 complex.人类耳聋肌张力障碍综合征是由DDP1/TIMM8a-TIMM13复合体组装缺陷引起的。
Hum Mol Genet. 2002 Mar 1;11(5):477-86. doi: 10.1093/hmg/11.5.477.
4
The syndrome of deafness-dystonia: clinical and genetic heterogeneity.耳聋-肌张力障碍综合征:临床和遗传异质性。
Mov Disord. 2013 Jun;28(6):795-803. doi: 10.1002/mds.25394. Epub 2013 Feb 15.
5
Deafness-Dystonia-Optic Neuronopathy Syndrome耳聋-肌张力障碍-视神经病变综合征
6
Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene.一名患有耳聋-肌张力障碍肽(DDP1)基因新突变患者的临床及分子学发现。
Brain. 2003 Aug;126(Pt 8):1814-20. doi: 10.1093/brain/awg174. Epub 2003 Jun 4.
7
Neuronal cell death in the visual cortex is a prominent feature of the X-linked recessive mitochondrial deafness-dystonia syndrome caused by mutations in the TIMM8a gene.视皮层中的神经元细胞死亡是由TIMM8a基因突变引起的X连锁隐性线粒体耳聋-肌张力障碍综合征的一个显著特征。
Ophthalmic Genet. 2001 Dec;22(4):207-23. doi: 10.1076/opge.22.4.207.2220.
8
Molecular genetics of a patient with Mohr-Tranebjaerg Syndrome due to a new mutation in the DDP1 gene.一名因DDP1基因新突变而患有莫尔-特拉内耶尔格综合征患者的分子遗传学研究
Neuromolecular Med. 2007;9(4):285-91. doi: 10.1007/s12017-007-8000-3. Epub 2007 Aug 3.
9
The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome.Mohr-Tranebjaerg 综合征的肌张力障碍表型谱。
Mov Disord. 2012 Jul;27(8):1034-40. doi: 10.1002/mds.25033. Epub 2012 Jun 26.
10
A Spanish sporadic case of deafness-dystonia (Mohr-Tranebjaerg) syndrome with a novel mutation in the gene encoding TIMM8a, a component of the mitochondrial protein translocase complexes.一例西班牙散发性耳聋-肌张力障碍(莫尔-特拉内耶尔格)综合征病例,其编码线粒体蛋白转位酶复合物组分TIMM8a的基因存在新突变。
Neuromuscul Disord. 2008 Dec;18(12):979-81. doi: 10.1016/j.nmd.2008.09.009. Epub 2008 Oct 25.

引用本文的文献

1
A novel TIMM8A mutation in Mohr-Tranebjaerg syndrome without hearing loss and with basal ganglia iron deposition.莫尔-特拉内布耶格综合征中一种新的TIMM8A突变,无听力损失且伴有基底节铁沉积。
Orphanet J Rare Dis. 2025 Jul 1;20(1):327. doi: 10.1186/s13023-025-03868-0.
2
The oncogenic role of TIMM8A in cancer and the mechanistic insights into the function in breast cancer cells.TIMM8A在癌症中的致癌作用及对其在乳腺癌细胞中功能的机制性见解。
Sci Rep. 2025 May 26;15(1):18374. doi: 10.1038/s41598-025-03331-x.
3
CHCHD2 rescues the mitochondrial dysfunction in iPSC-derived neurons from patient with Mohr-Tranebjaerg syndrome.

本文引用的文献

1
Function of hTim8a in complex IV assembly in neuronal cells provides insight into pathomechanism underlying Mohr-Tranebjærg syndrome.hTim8a 在神经元细胞复合物 IV 组装中的功能为莫尔-特兰贝贾尔综合征发病机制提供了新的见解。
Elife. 2019 Nov 4;8:e48828. doi: 10.7554/eLife.48828.
2
Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of ELX-02, a Potential Treatment for Genetic Disorders Caused by Nonsense Mutations, in Healthy Volunteers.ELX-02 单剂量递增给药的安全性、耐受性和药代动力学研究,ELX-02 是一种治疗由无义突变引起的遗传疾病的潜在药物,在健康志愿者中进行。
Clin Pharmacol Drug Dev. 2019 Nov;8(8):984-994. doi: 10.1002/cpdd.647. Epub 2019 Jan 16.
3
CHCHD2可挽救莫尔-特拉内布尔格综合征患者诱导多能干细胞衍生神经元中的线粒体功能障碍。
Cell Death Dis. 2025 Mar 12;16(1):173. doi: 10.1038/s41419-025-07472-9.
4
Mitochondrial microproteins: critical regulators of protein import, energy production, stress response pathways, and programmed cell death.线粒体小蛋白:蛋白输入、能量产生、应激反应途径和程序性细胞死亡的关键调节因子。
Am J Physiol Cell Physiol. 2023 Oct 1;325(4):C807-C816. doi: 10.1152/ajpcell.00189.2023. Epub 2023 Aug 29.
5
HOXC13-driven TIMM13 overexpression promotes osteosarcoma cell growth.HOXC13 驱动的 TIMM13 过表达促进骨肉瘤细胞生长。
Cell Death Dis. 2023 Jul 5;14(7):398. doi: 10.1038/s41419-023-05910-0.
6
Case report: Mohr-Tranebjaerg syndrome: hearing impairment as the onset of an insidious disorder with high recurrence risk.病例报告:莫尔-特拉内耶尔格综合征:听力障碍作为一种隐匿性疾病的首发症状,复发风险高。
Front Neurol. 2023 Jun 1;14:1161940. doi: 10.3389/fneur.2023.1161940. eCollection 2023.
7
Identification of Timm13 protein translocase of the mitochondrial inner membrane as a potential mediator of liver fibrosis based on bioinformatics and experimental verification.基于生物信息学和实验验证鉴定 Timm13 蛋白作为潜在的肝纤维化介导线粒体内膜转位酶。
J Transl Med. 2023 Mar 10;21(1):188. doi: 10.1186/s12967-023-04037-2.
8
DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer.DNA 甲基化作为头颈部癌症的诊断、预后和预测生物标志物。
Int J Mol Sci. 2023 Feb 3;24(3):2996. doi: 10.3390/ijms24032996.
9
Genetic etiological analysis of auditory neuropathy spectrum disorder by next-generation sequencing.通过下一代测序对听觉神经病谱系障碍进行遗传病因分析。
Front Neurol. 2022 Dec 8;13:1026695. doi: 10.3389/fneur.2022.1026695. eCollection 2022.
10
TIMM8A is associated with dysfunction of immune cell in BRCA and UCEC for predicting anti-PD-L1 therapy efficacy.TIMM8A 与 BRCA 和 UCEC 免疫细胞功能障碍相关,可预测抗 PD-L1 治疗疗效。
World J Surg Oncol. 2022 Oct 7;20(1):336. doi: 10.1186/s12957-022-02736-6.
Phenotype prediction of Mohr-Tranebjaerg syndrome (MTS) by genetic analysis and initial auditory neuropathy.
通过基因分析和初始听觉神经病对莫尔-特拉内伯格综合征(MTS)进行表型预测
BMC Med Genet. 2019 Jan 11;20(1):11. doi: 10.1186/s12881-018-0741-3.
4
First Report of a Filipino with Mohr-Tranebjaerg Syndrome.首例菲律宾人患莫尔-特拉内耶尔格综合征的报告。
Mov Disord Clin Pract. 2015 Aug 26;2(4):417-419. doi: 10.1002/mdc3.12210. eCollection 2015 Dec.
5
Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy.基因诊断作为杜氏肌营养不良症个性化治疗的工具。
Acta Myol. 2016 Dec;35(3):122-127.
6
Therapeutics based on stop codon readthrough.基于终止密码子通读的疗法。
Annu Rev Genomics Hum Genet. 2014;15:371-94. doi: 10.1146/annurev-genom-091212-153527. Epub 2014 Apr 18.
7
The syndrome of deafness-dystonia: clinical and genetic heterogeneity.耳聋-肌张力障碍综合征:临床和遗传异质性。
Mov Disord. 2013 Jun;28(6):795-803. doi: 10.1002/mds.25394. Epub 2013 Feb 15.
8
The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome.Mohr-Tranebjaerg 综合征的肌张力障碍表型谱。
Mov Disord. 2012 Jul;27(8):1034-40. doi: 10.1002/mds.25033. Epub 2012 Jun 26.
9
Mitochondrial division ensures the survival of postmitotic neurons by suppressing oxidative damage.线粒体分裂通过抑制氧化损伤来确保有丝分裂后神经元的存活。
J Cell Biol. 2012 May 14;197(4):535-51. doi: 10.1083/jcb.201110034. Epub 2012 May 7.
10
Alterations in expression levels of deafness dystonia protein 1 affect mitochondrial morphology.耳聋肌张力蛋白 1 的表达水平变化影响线粒体形态。
Hum Mol Genet. 2012 Jan 15;21(2):287-99. doi: 10.1093/hmg/ddr458. Epub 2011 Oct 7.